Drug augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: what does the evidence point to?
- PMID: 26214531
- DOI: 10.1097/MNM.0000000000000356
Drug augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: what does the evidence point to?
Comment in
-
Drug-augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: What does the evidence point to?Nucl Med Commun. 2015 Sep;36(9):966. doi: 10.1097/MNM.0000000000000355. Nucl Med Commun. 2015. PMID: 26214532 No abstract available.
Comment on
-
Comparison of phenobarbitone and ursodeoxycholic acid in drug-augmented hepatobiliary scintigraphy for excluding the diagnosis of obstructive cholestasis in neonatal cholestasis syndrome.Nucl Med Commun. 2015 Aug;36(8):827-32. doi: 10.1097/MNM.0000000000000322. Nucl Med Commun. 2015. PMID: 25920049
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
